Immucor to Buy BioArray Solutions for $117M To Grow Transfusion, Transplantation Reach
March 18, 2008
Immucor to Buy BioArray Solutions for $117M To Grow Transfusion, Transplantation Reach
By Justin Petrone
The company envisions making BioArray Solutions’ platform the central piece of an automated system that will eventually succeed Immucor’s current blood-screening platform, the Galileo.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.